Up next
Author
Share article
The post has been shared by 0 people.
Facebook 0
Twitter 0
Pinterest 0
Mail 0

© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

(Reuters) – The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron (NASDAQ:) Pharmaceuticals’ eye disease drug Eylea, the company said in a statement on Friday.

Reuters

Source link

You May Also Like

Grow Your Freelance Business with This CES-Featured Job Application AI Tool for Just $67 | Entrepreneur

Disclosure: Our goal is to feature products and services that we think…

Make Recession-Proofing Your Finances Part of Your Tax Season | Entrepreneur

Disclosure: Our goal is to feature products and services that we think…

How to Craft a Unique Brand Narrative for Your Startup | Entrepreneur

Opinions expressed by Entrepreneur contributors are their own. For any startup business,…

Who’s Rooting Hardest for a Sam Bankman-Fried Conviction? The Crypto Industry.

Travis Kling has spent a lot of time this year focusing on…